Introduction: Gloria Kwangja Lee is a prominent inventor based in Ladera Ranch, California, known for her groundbreaking work in the field of lipoprotein analysis. With an impressive portfolio of 12 patents, she has significantly advanced the methodologies used for diagnostic purposes in healthcare, particularly concerning cardiovascular health.

Latest Patents: Among her notable contributions is her recent patent titled "Lipoprotein analysis by differential charged-particle mobility." This invention outlines methods for preparing lipoproteins from biological samples, including HDL, LDL, Lp(a), IDL, and VLDL. These methods employ differential charged particle mobility analysis techniques, which can analyze lipoprotein size distributions and assess associated health risks. This invention is crucial for determining cardiovascular conditions and evaluating responses to therapeutic interventions, using lipoprotein size distributions obtained from her innovative methods.

Career Highlights: Gloria Kwangja Lee's expert knowledge and creativity in her field have led her to work with Quest Diagnostics Investments, Inc., where she has been able to apply her expertise in a dynamic environment. Her work blends research and practical applications, bridging gaps in diagnostic testing.

Collaborations: In her career, Gloria has collaborated with respected colleagues such as Michael P. Caulfield and Richard E. Reitz. These partnerships highlight her ability to work alongside other distinguished professionals, contributing to the advancement of lipoprotein analysis technology.

Conclusion: Gloria Kwangja Lee's contributions to lipoprotein analysis are invaluable in the healthcare sector. Her innovative inventions not only expand the understanding of cardiovascular health but also pave the way for improved diagnostic techniques. With her 12 patents, she stands as a beacon of innovation and a role model for aspiring inventors in the field.

This text is generated by artificial intelligence and may not be accurate.